3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Anxiety Disorders
3
Pain
2
Gastrointestinal Neoplasms
2
Depression
2
Acute Pain
2
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain, Postoperative
1
Otolaryngeal Cancer
1
Mucositis
1
Lymphoma, Follicular
1
Head and Neck Neoplasms
1
Fatigue
1
Colorectal Neoplasms
1
Cancer: Breakthrough Pain
1
Agnosia
1
Interventions
Morphine
1
Ketamine
1
Chitosan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Cancer: Breakthrough Pain
×
Ketamine
×
Clear all
NCT02591017
2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3
Terminated
11 enrolled